Gregory Moore

Person

Azusa, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 12,359,002
- Issue date Jul 15, 2025
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 12,129,309
- Issue date Oct 29, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind somatostatin receptor 2
- Patent number 12,054,545
- Issue date Aug 6, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Untargeted and targeted IL-10 Fc-fusion proteins
- Patent number 12,006,345
- Issue date Jun 11, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,945,880
- Issue date Apr 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,919,958
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,859,011
- Issue date Jan 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies that bind to CD38 and CD3
- Patent number 11,840,579
- Issue date Dec 12, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric proteins
- Patent number 11,814,423
- Issue date Nov 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific binding agents binding to CLDN18.2 and CD3
- Patent number 11,739,145
- Issue date Aug 29, 2023
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibody variable regions
- Patent number 11,718,667
- Issue date Aug 8, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,673,972
- Issue date Jun 13, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric proteins
- Patent number 11,634,506
- Issue date Apr 25, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and PSMA
- Patent number 11,623,957
- Issue date Apr 11, 2023
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...
- Patent number 11,618,776
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,591,401
- Issue date Feb 28, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-STEAP1 antigen-binding protein
- Patent number 11,530,274
- Issue date Dec 20, 2022
- Amgen Inc.
- Olivier Nolan-Stevaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind ENPP3 and CD3
- Patent number 11,472,890
- Issue date Oct 18, 2022
- Xencor, Inc.
- Rumana Rashid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,447,552
- Issue date Sep 20, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,434,295
- Issue date Sep 6, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric Fc variants
- Patent number 11,401,348
- Issue date Aug 2, 2022
- Xencor, Inc.
- Gregory Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 11,352,442
- Issue date Jun 7, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 11,312,770
- Issue date Apr 26, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric proteins
- Patent number 11,299,554
- Issue date Apr 12, 2022
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,236,170
- Issue date Feb 1, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,225,528
- Issue date Jan 18, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind somatostatin receptor 2
- Patent number 11,225,521
- Issue date Jan 18, 2022
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,111,315
- Issue date Sep 7, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFI...
- Publication number 20250230262
- Publication date Jul 17, 2025
- Xencor, Inc.
- Gregory L. Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD20 ANTIBODIES AND THERAPEUTIC USES THEREOF
- Publication number 20250197519
- Publication date Jun 19, 2025
- Xencor, Inc.
- Matthew BERNETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-STEAP1 ANTIGEN-BINDING PROTEIN
- Publication number 20250154281
- Publication date May 15, 2025
- Amgen Inc.
- Olivier Nolan-Stevaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES
- Publication number 20250122299
- Publication date Apr 17, 2025
- Xencor, Inc.
- Gregory L. Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
- Publication number 20250114440
- Publication date Apr 10, 2025
- Xencor, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20250109214
- Publication date Apr 3, 2025
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20250109215
- Publication date Apr 3, 2025
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD28 X ANTI-TROP2 ANTIBODIES
- Publication number 20250084179
- Publication date Mar 13, 2025
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-ENPP3 ANTIBODIES
- Publication number 20250084186
- Publication date Mar 13, 2025
- Xencor, Inc.
- Alex Nisthal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD28 COMPOSITIONS
- Publication number 20250043001
- Publication date Feb 6, 2025
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED ANTIBODY VARIABLE REGIONS
- Publication number 20250034247
- Publication date Jan 30, 2025
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B-CELL MATURATION ANTIGEN (BCMA) BINDING DOMAIN COMPOSITIONS
- Publication number 20240392025
- Publication date Nov 28, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORTHOGONAL MULTIMERIC PROTEINS
- Publication number 20240360220
- Publication date Oct 31, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-STEAP1 ANTIGEN-BINDING PROTEIN
- Publication number 20240301087
- Publication date Sep 12, 2024
- Amgen Inc.
- Olivier Nolan-Stevaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CLAUDIN18.2 AND CD3
- Publication number 20240247062
- Publication date Jul 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20240218082
- Publication date Jul 4, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL18-FC FUSION PROTEINS
- Publication number 20240166705
- Publication date May 23, 2024
- Xencor, Inc.
- Alex NISTHAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC PROTEINS
- Publication number 20240092871
- Publication date Mar 21, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-TROP2 ANTIBODIES
- Publication number 20240059786
- Publication date Feb 22, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20240026002
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3
- Publication number 20240018234
- Publication date Jan 18, 2024
- Astellas Pharma Europe BV
- Matthew BERNETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED ANTIBODY VARIABLE REGIONS
- Publication number 20230399401
- Publication date Dec 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28
- Publication number 20230383012
- Publication date Nov 30, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20230365717
- Publication date Nov 16, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD28 X ANTI-MSLN ANTIBODIES
- Publication number 20230340128
- Publication date Oct 26, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...
- Publication number 20230340053
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20230322961
- Publication date Oct 12, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL HETERODIMERIC PROTEINS
- Publication number 20230279154
- Publication date Sep 7, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20230265218
- Publication date Aug 24, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 COMPOSITIONS
- Publication number 20230257466
- Publication date Aug 17, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY

Gregory Moore

Person

Patents Grantslast 30 patents

Heterodimeric antibodies that bind CD3 and tumor antigens

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Heterodimeric antibodies that bind CD3 and CD38

Heterodimeric antibodies that bind somatostatin receptor 2

Untargeted and targeted IL-10 Fc-fusion proteins

Heterodimeric antibodies that bind CD3 and tumor antigens

Anti-CD28 compositions

Heterodimeric antibodies that bind CD3 and tumor antigens

Bispecific antibodies that bind to CD38 and CD3

Heterodimeric proteins

Bispecific binding agents binding to CLDN18.2 and CD3

Optimized antibody variable regions

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric proteins

Heterodimeric antibodies that bind CD3 and PSMA

Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...

Anti-CD28 compositions

Anti-STEAP1 antigen-binding protein

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind ENPP3 and CD3

Methods and compositions for inhibiting CD32B expressing cells

Methods and compositions for inhibiting CD32B expressing cells

Heterodimeric Fc variants

Heterodimeric antibodies that bind CD3 and CD38

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Heterodimeric proteins

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind somatostatin receptor 2

Heterodimeric antibodies that bind CD3 and tumor antigens

Patents Applicationslast 30 patents

HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFI...

ANTI-CD20 ANTIBODIES AND THERAPEUTIC USES THEREOF

ANTI-STEAP1 ANTIGEN-BINDING PROTEIN

ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTI-CD28 X ANTI-TROP2 ANTIBODIES

ANTI-CD28 X ANTI-ENPP3 ANTIBODIES

ANTI-CD28 COMPOSITIONS

OPTIMIZED ANTIBODY VARIABLE REGIONS

B-CELL MATURATION ANTIGEN (BCMA) BINDING DOMAIN COMPOSITIONS

ORTHOGONAL MULTIMERIC PROTEINS

ANTI-STEAP1 ANTIGEN-BINDING PROTEIN

HETERODIMERIC ANTIBODIES THAT BIND CLAUDIN18.2 AND CD3

ANTI-CD28 X ANTI-PSMA ANTIBODIES

IL18-FC FUSION PROTEINS

HETERODIMERIC PROTEINS

ANTI-CD28 X ANTI-TROP2 ANTIBODIES

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

OPTIMIZED ANTIBODY VARIABLE REGIONS

ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTI-CD28 X ANTI-MSLN ANTIBODIES

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...

ANTI-CD28 X ANTI-PSMA ANTIBODIES

NOVEL HETERODIMERIC PROTEINS

ANTI-CD28 X ANTI-PSMA ANTIBODIES

ANTI-CD28 COMPOSITIONS